TY - JOUR
T1 - Apo A-I and apo E concentrations in cerebrospinal fluids of patients with acute meningitis
AU - Song, Hua
AU - Seishima, Mitsuru
AU - Saito, Kuniaki
AU - Maeda, Satoshi
AU - Takemura, Masao
AU - Noma, Akio
AU - Kondo, Akira
AU - Manabe, Mitsuhisa
AU - Urakami, Katsuya
AU - Nakashima, Kenji
PY - 1998/5
Y1 - 1998/5
N2 - It has been demonstrated that apolipoproteins found in cerebrospinal fluid (CSF) play an important role in lipid metabolism in the central nervous system (CNS). Previously we reported that CSF apo A-I levels increased with the severity of neurological damage in poliovirus-infected macaques. In the present study, apo A-I was quantitatively analysed in CSF from patients with or without neurological diseases. In controls, CSF apo A-I level was significantly higher in males; 3.83 (0.40) mg/L, mean (SEM) (n = 19) compared with females, 2.42 (0.26) mg/L (n = 23, P < 0.05). CSF apo A-I concentrations in patients with acute meningitis increased at the active stage, 7.74 (1.78) mg/L (n = 10), but returned to basal concentrations at the convalescent stage 2.72 (0.38) mg/L (n = 10), while the CSF apo A-I level in patients with other neurological diseases remained in the same range as in controls. By contrast, CSF apo E was consistently elevated at either stage of acute meningitis. Furthermore, it was found that the levels of CSF apo A-I, but not of apo E, correlated positively with CSF albumin concentrations. These findings suggest that the CSF apo A-I and apo E have different origins and may play different roles in the lipoprotein metabolism in CNS.
AB - It has been demonstrated that apolipoproteins found in cerebrospinal fluid (CSF) play an important role in lipid metabolism in the central nervous system (CNS). Previously we reported that CSF apo A-I levels increased with the severity of neurological damage in poliovirus-infected macaques. In the present study, apo A-I was quantitatively analysed in CSF from patients with or without neurological diseases. In controls, CSF apo A-I level was significantly higher in males; 3.83 (0.40) mg/L, mean (SEM) (n = 19) compared with females, 2.42 (0.26) mg/L (n = 23, P < 0.05). CSF apo A-I concentrations in patients with acute meningitis increased at the active stage, 7.74 (1.78) mg/L (n = 10), but returned to basal concentrations at the convalescent stage 2.72 (0.38) mg/L (n = 10), while the CSF apo A-I level in patients with other neurological diseases remained in the same range as in controls. By contrast, CSF apo E was consistently elevated at either stage of acute meningitis. Furthermore, it was found that the levels of CSF apo A-I, but not of apo E, correlated positively with CSF albumin concentrations. These findings suggest that the CSF apo A-I and apo E have different origins and may play different roles in the lipoprotein metabolism in CNS.
UR - http://www.scopus.com/inward/record.url?scp=0031744515&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031744515&partnerID=8YFLogxK
U2 - 10.1177/000456329803500310
DO - 10.1177/000456329803500310
M3 - Article
C2 - 9635107
AN - SCOPUS:0031744515
SN - 0004-5632
VL - 35
SP - 408
EP - 414
JO - Annals of Clinical Biochemistry
JF - Annals of Clinical Biochemistry
IS - 3
ER -